WVE 13.51 (+2.43%)
SG9999014716BiotechnologyBiotechnology

WAVE Life Sciences (WVE) Stock Highlights

13.51 | +2.43%
2024-12-23 03:08:42
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

Statistics

Range Today
12.93 13.85
Volume Today 4.46M
Range 1 Year
3.5 16.74
Volume 1 Year 276.09M
Range 3 Year
1.16 16.74
Volume 3 Year 507.71M
Range 10 Year
1.16 56
Volume 10 Year 1.04B

Highlights

Market Capitalization 2.5B (mid)
Floating Shares 65.05M
Current Price 13.51
Price To Earnings -23.33
Price To Revenue 17.5
Earnings Per Share -0.63
Payout Ratio 0%

Performance

Latest +2.43%
1 Month -5.06%
3 Months +127.06%
6 Months +138.69%
1 Year +170.2%
3 Years +319.57%
5 Years -14.17%
10 Years -20.76%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.